Patents by Inventor Ruth Baxter

Ruth Baxter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11717532
    Abstract: Described herein are methods of treating wounds, the method comprising administering to a subject an effective amount of a composition comprising a soluble or derivatized chitosan wherein the soluble or derivatized chitosan when administered contacts the wound, thereby treating the wound.
    Type: Grant
    Filed: March 16, 2018
    Date of Patent: August 8, 2023
    Assignee: SYNEDGEN, INC.
    Inventors: Shenda M. Baker, William P. Wiesmann, Ruth Baxter
  • Publication number: 20200061192
    Abstract: Described herein are compositions comprising a derivatized polyglucosamine and a small molecule, peptide, or protein and related methods of use, e.g., to deliver a small molecule, peptide, or protein to cells (e.g., cancer cells) or tissues (e.g., mucosal membrane and epithelial membrane), e.g., to treat a disease or condition at a subject.
    Type: Application
    Filed: May 1, 2019
    Publication date: February 27, 2020
    Inventors: Shenda M. Baker, Ruth Baxter, William P. Wiesmann
  • Publication number: 20180200286
    Abstract: Described herein are methods of treating wounds, the method comprising administering to a subject an effective amount of a composition comprising a soluble or derivatized chitosan wherein the soluble or derivatized chitosan when administered contacts the wound, thereby treating the wound.
    Type: Application
    Filed: March 16, 2018
    Publication date: July 19, 2018
    Inventors: Shenda M. Baker, William P. Wiesmann, Ruth Baxter
  • Publication number: 20170119810
    Abstract: Described herein are methods of treating wounds, the method comprising administering to a subject an effective amount of a composition comprising a soluble or derivatized chitosan wherein the soluble or derivatized chitosan when administered contacts the wound, thereby treating the wound.
    Type: Application
    Filed: June 3, 2016
    Publication date: May 4, 2017
    Inventors: Shenda Baker, William P. Wiesmann, Ruth Baxter
  • Patent number: 9439925
    Abstract: Described herein are methods of treating wounds, the method comprising administering to a subject an effective amount of a composition comprising a soluble or derivatized chitosan wherein the soluble or derivatized chitosan when administered contacts the wound, thereby treating the wound.
    Type: Grant
    Filed: April 6, 2011
    Date of Patent: September 13, 2016
    Assignee: SYNEDGEN, INC.
    Inventors: Shenda Baker, William P. Wiesmann, Ruth Baxter
  • Publication number: 20150031610
    Abstract: Described herein are compositions comprising a derivatized polyglucosamine and a small molecule, peptide, or protein and related methods of use, e.g., to deliver a small molecule, peptide, or protein to cells (e.g., cancer cells) or tissues (e.g., mucosal membrane and epithelial membrane), e.g., to treat a disease or condition in a subject.
    Type: Application
    Filed: March 4, 2013
    Publication date: January 29, 2015
    Inventors: Shenda M. Baker, William P. Wiesmann, Ruth Baxter
  • Publication number: 20130210761
    Abstract: Described herein are methods of treating wounds, the method comprising administering to a subject an effective amount of a composition comprising a soluble or derivatized chitosan wherein the soluble or derivatized chitosan when administered contacts the wound, thereby treating the wound.
    Type: Application
    Filed: April 6, 2011
    Publication date: August 15, 2013
    Applicant: SYNEDGEN, INC.
    Inventors: Shenda Baker, William P. Wiesmann, Ruth Baxter
  • Publication number: 20120295355
    Abstract: The present invention is directed to the delivery of nucleic acids in a non-viral vector to cells by positively charged chitosan derivatives, including but not limited to chitosan-arginine, chitosan-lysine and chitosan-histidine.
    Type: Application
    Filed: March 12, 2012
    Publication date: November 22, 2012
    Inventors: Shenda Baker, William P. Wiesmann, Ruth Baxter, Snezna Rogelj
  • Publication number: 20110059069
    Abstract: Methods of treatment, diagnosis and screening related to GAPR-1 are disclosed.
    Type: Application
    Filed: September 22, 2006
    Publication date: March 10, 2011
    Inventors: Ruth Baxter, Humphrey Gardner